NIAID Banner Logo Image

Opportunistic Infections Citation List: March 27 - April 9, 2015

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Synthesis, Spectroscopic, Thermal and Antimicrobial Studies of Neodymium(III) and Samarium(III) Complexes Derived from Tetradentate Ligands Containing N and S Donor Atoms. Ain, Q., S.K. Pandey, O.P. Pandey, and S.K. Sengupta. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2015. 140: p. 27-34. PMID[25579799].

[PubMed]. OI_0327-040915.


2. Antifungal Activity of the Essential Oil of Angelica major against Candida, Cryptococcus, Aspergillus and Dermatophyte Species. Cavaleiro, C., L. Salgueiro, M.J. Goncalves, K. Hrimpeng, J. Pinto, and E. Pinto. Journal of Natural Medicines, 2015. 69(2): p. 241-248. PMID[25576097].

[PubMed]. OI_0327-040915.


3. Antimicrobial and Antiquorum-sensing Studies. Part 3: Synthesis and Biological Evaluation of New Series of [1,3,4]Thiadiazoles and Fused [1,3,4]Thiadiazoles. El-Gohary, N.S. and M.I. Shaaban. Archiv der Pharmazie, 2015. 348(4): p. 283-297. PMID[25773477].

[PubMed]. OI_0327-040915.


4. Antimicrobial Activity of Turmeric Extract and its Potential use in Food Industry. Gul, P. and J. Bakht. Journal of Food Science and Technology, 2015. 52(4): p. 2272-2279. PMID[25829609].

[PubMed]. OI_0327-040915.


5. Synthesis and Biological Evaluation of Fluconazole Analogs with Triazole-modified Scaffold as Potent Antifungal Agents. Hashemi, S.M., H. Badali, H. Irannejad, M. Shokrzadeh, and S. Emami. Bioorganic & Medicinal Chemistry, 2015. 23(7): p. 1481-1491. PMID[25740636].

[PubMed]. OI_0327-040915.


6. Clinical Isolates of Candida albicans, Candida tropicalis, and Candida krusei have Different Susceptibilities to Co(II) and Cu(II) Complexes of 1,10-Phenanthroline. Hoffman, A.E., L. Miles, T.J. Greenfield, C. Shoen, M. DeStefano, M. Cynamon, and R.P. Doyle. Biometals, 2015. 28(2): p. 415-423. PMID[25663372].

[PubMed]. OI_0327-040915.


7. Synthesis, Characterization, Crystal Structure and Antimicrobial Activity of Copper(II) Complexes with the Schiff Base Derived from 2-Hydroxy-4-methoxybenzaldehyde. Pahontu, E., D.C. Ilies, S. Shova, C. Paraschivescu, M. Badea, A. Gulea, and T. Rosu. Molecules, 2015. 20(4): p. 5771-5792. PMID[25849802].

[PubMed]. OI_0327-040915.


8. Antibacterial, Antifungal and in Vitro Antileukaemia Activity of Metal Complexes with Thiosemicarbazones. Pahontu, E., F. Julea, T. Rosu, V. Purcarea, Y. Chumakov, P. Petrenco, and A. Gulea. Journal of Cellular and Molecular Medicine, 2015. 19(4): p. 865-878. PMID[25708540].

[PubMed]. OI_0327-040915.


9. In Vitro Evaluation of the Acquisition of Resistance, Antifungal Activity and Synergism of Brazilian Red Propolis with Antifungal Drugs on Candida Spp. Pippi, B., A.J. Lana, R.C. Moraes, C.M. Guez, M. Machado, L.F. de Oliveira, G. Lino von Poser, and A.M. Fuentefria. Journal of Applied Microbiology, 2015. 118(4): p. 839-850. PMID[25565139].

[PubMed]. OI_0327-040915.


10. Efficacy of Angelica archangelica Essential Oil, Phenyl ethyl Alcohol and alpha-Terpineol against Isolated Molds from Walnut and their Antiaflatoxigenic and Antioxidant Activity. Prakash, B., P. Singh, R. Goni, A.K. Raina, and N.K. Dubey. Journal of Food Science and Technology, 2015. 52(4): p. 2220-2228. PMID[25829603].

[PubMed]. OI_0327-040915.


11. Synthesis of Silver Nanoparticles by Phoma gardeniae and in Vitro Evaluation of their Efficacy against Human Disease-causing Bacteria and Fungi. Rai, M., A.P. Ingle, A. Gade, and N. Duran. IET Nanobiotechnology, 2015. 9(2): p. 71-75. PMID[25829172].

[PubMed]. OI_0327-040915.


12. Assessment of Conformational, Spectral, Antimicrobial Activity, Chemical Reactivity and NLO Application of Pyrrole-2,5-dicarboxaldehyde bis(oxaloyldihydrazone). Rawat, P. and R.N. Singh. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2015. 140: p. 344-355. PMID[25615679].

[PubMed]. OI_0327-040915.


13. Beta-Lactam Antibiotics and Vancomycin Inhibit the Growth of Planktonic and Biofilm Candida spp.: An Additional Benefit of Antibiotic-lock Therapy. Sidrim, J.J., C.E. Teixeira, R.A. Cordeiro, R.S. Brilhante, D.S. Castelo-Branco, S.P. Bandeira, L.P. Alencar, J.S. Oliveira, A.J. Monteiro, J.L. Moreira, T.J. Bandeira, and M.F. Rocha. International Journal of Antimicrobial Agents, 2015. 45(4): p. 420-423. PMID[25631674].

[PubMed]. OI_0327-040915.


14. In Vitro Antifungal Activity and in Vivo Antibiofilm Activity of Cerium nitrate against Candida Species. Silva-Dias, A., I.M. Miranda, J. Branco, L. Cobrado, M. Monteiro-Soares, C. Pina-Vaz, and A.G. Rodrigues. Journal of Antimicrobial Chemotherapy, 2015. 70(4): p. 1083-1093. PMID[25558078].

[PubMed]. OI_0327-040915.


15. Biosynthesis, Characterization, and Antimicrobial Applications of Silver Nanoparticles. Singh, P., Y.J. Kim, H. Singh, C. Wang, K.H. Hwang, A. Farh Mel, and D.C. Yang. International Journal of Nanomedicine, 2015. 10: p. 2567-2577. PMID[25848272].

[PubMed]. OI_0327-040915.


16. Comparison of Essential Oil Composition and Antimicrobial Activity of Coriandrum sativum L. Extracted by Hydrodistillation and Microwave-assisted Hydrodistillation. Sourmaghi, M.H., G. Kiaee, F. Golfakhrabadi, H. Jamalifar, and M. Khanavi. Journal of Food Science and Technology, 2015. 52(4): p. 2452-2457. PMID[25829632].

[PubMed]. OI_0327-040915.


17. Synergistic Activity of Magnolol with Azoles and its Possible Antifungal Mechanism against Candida albicans. Sun, L.M., K. Liao, S. Liang, P.H. Yu, and D.Y. Wang. Journal of Applied Microbiology, 2015. 118(4): p. 826-838. PMID[25641229].

[PubMed]. OI_0327-040915.


18. Rapid 'One-Pot' Synthesis of a Novel Benzimidazole-5-carboxylate and its Hydrazone Derivatives as Potential Anti-inflammatory and Antimicrobial Agents. Vasantha, K., G. Basavarajaswamy, M. Vaishali Rai, P. Boja, V.R. Pai, N. Shruthi, and M. Bhat. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1420-1426. PMID[25765910].

[PubMed]. OI_0327-040915.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

19. Antitubercular Activity of Ru (II) Isoniazid Complexes. Aguiar, I., A. Tavares, A.C. Roveda, Jr., A.C. da Silva, L.B. Marino, E.O. Lopes, F.R. Pavan, L.G. Lopes, and D.W. Franco. European Journal of Pharmaceutical Sciences, 2015. 70: p. 45-54. PMID[25638418].

[PubMed]. OI_0327-040915.


20. Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs. Blanco, D., E. Perez-Herran, M. Cacho, L. Ballell, J. Castro, R. Gonzalez Del Rio, J.L. Lavandera, M.J. Remuinan, C. Richards, J. Rullas, M.J. Vazquez-Muniz, E. Woldu, M.C. Zapatero-Gonzalez, I. Angulo-Barturen, A. Mendoza, and D. Barros. Antimicrobial Agents and Chemotherapy, 2015. 59(4): p. 1868-1875. PMID[25583730].

[PubMed]. OI_0327-040915.


21. Nanomolar Inhibitors of Mycobacterium tuberculosis Glutamine Synthetase 1: Synthesis, Biological Evaluation and X-ray Crystallographic Studies. Couturier, C., S. Silve, R. Morales, B. Pessegue, S. Llopart, A. Nair, A. Bauer, B. Scheiper, C. Poverlein, A. Ganzhorn, S. Lagrange, and E. Bacque. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1455-1459. PMID[25770781].

[PubMed]. OI_0327-040915.


22. 3-Benzylidene-4-chromanones: A Novel Cluster of Anti-tubercular Agents. Das, U., T. Lorand, S.G. Dimmock, P. Perjesi, and J.R. Dimmock. Journal of Enzyme Inhibition and Medicinal Chemistry, 2015. 30(2): p. 259-263. PMID[24939095].

[PubMed]. OI_0327-040915.


23. Compounds Targeting Disulfide Bond Forming Enzyme DsbB of Gram-negative Bacteria. Landeta, C., J.L. Blazyk, F. Hatahet, B.M. Meehan, M. Eser, A. Myrick, L. Bronstain, S. Minami, H. Arnold, N. Ke, E.J. Rubin, B.C. Furie, B. Furie, J. Beckwith, R. Dutton, and D. Boyd. Nature Chemical Biology, 2015. 11(4): p. 292-298. PMID[25686372].

[PubMed]. OI_0327-040915.


24. Synthesis and Antitubercular Evaluation of 4-Carbonyl Piperazine Substituted 1,3-Benzothiazin-4-one Derivatives. Peng, C.T., C. Gao, N.Y. Wang, X.Y. You, L.D. Zhang, Y.X. Zhu, Y. Xv, W.Q. Zuo, K. Ran, H.X. Deng, Q. Lei, K.J. Xiao, and L.T. Yu. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1373-1376. PMID[25754492].

[PubMed]. OI_0327-040915.


25. Synthesis, in Vitro Anticancer and Antimycobacterial Evaluation of New 5-(2,5-Dimethoxyphenyl)-1,3,4-thiadiazole-2-amino Derivatives. Polkam, N., P. Rayam, J.S. Anireddy, S. Yennam, H.S. Anantaraju, S. Dharmarajan, Y. Perumal, S.S. Kotapalli, R. Ummanni, and S. Balasubramanian. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1398-1402. PMID[25765907].

[PubMed]. OI_0327-040915.


26. Development of 2-Amino-5-phenylthiophene-3-carboxamide Derivatives as Novel Inhibitors of Mycobacterium tuberculosis DNA GyrB Domain. Saxena, S., G. Samala, J. Renuka, J.P. Sridevi, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry, 2015. 23(7): p. 1402-1412. PMID[25766629].

[PubMed]. OI_0327-040915.


27. Enhancement of Antibiotic Activity against Multidrug-resistant Bacteria by the Efflux Pump Inhibitor 3,4-Dibromopyrrole-2,5-dione Isolated from a Pseudoalteromonas sp. Whalen, K.E., K.L. Poulson-Ellestad, R.W. Deering, D.C. Rowley, and T.J. Mincer. Journal of Natural Products, 2015. 78(3): p. 402-412. PMID[25646964].

[PubMed]. OI_0327-040915.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

28. Biologically Active Carbazole Derivatives: Focus on Oxazinocarbazoles and Related Compounds. Bouaziz, Z., S. Issa, J. Gentili, A. Gratz, A. Bollacke, M. Kassack, J. Jose, L. Herfindal, G. Gausdal, S.O. Doskeland, C. Mullie, P. Sonnet, C. Desgrouas, N. Taudon, G. Valdameri, A. Di Pietro, M. Baitiche, and M. Le Borgne. Journal of Enzyme Inhibition and Medicinal Chemistry, 2015. 30(2): p. 180-188. PMID[24697298].

[PubMed]. OI_0327-040915.


29. N10,N11-di-Alkylamine indolo[3,2-b]quinolines as Hemozoin Inhibitors: Design, Synthesis and Antiplasmodial Activity. Figueiras, M., L. Coelho, K.J. Wicht, S.A. Santos, J. Lavrado, J. Gut, P.J. Rosenthal, F. Nogueira, T.J. Egan, R. Moreira, and A. Paulo. Bioorganic & Medicinal Chemistry, 2015. 23(7): p. 1530-1539. PMID[25725608].

[PubMed]. OI_0327-040915.


30. Triaminopyrimidine is a Fast-killing and Long-acting Antimalarial Clinical Candidate. Hameed, P.S., S. Solapure, V. Patil, P.P. Henrich, P.A. Magistrado, S. Bharath, K. Murugan, P. Viswanath, J. Puttur, A. Srivastava, E. Bellale, V. Panduga, G. Shanbag, D. Awasthy, S. Landge, S. Morayya, K. Koushik, R. Saralaya, A. Raichurkar, N. Rautela, N. Roy Choudhury, A. Ambady, R. Nandishaiah, J. Reddy, K.R. Prabhakar, S. Menasinakai, S. Rudrapatna, M. Chatterji, M.B. Jimenez-Diaz, M.S. Martinez, L.M. Sanz, O. Coburn-Flynn, D.A. Fidock, A.K. Lukens, D.F. Wirth, B. Bandodkar, K. Mukherjee, R.E. McLaughlin, D. Waterson, L. Rosenbrier-Ribeiro, K. Hickling, V. Balasubramanian, P. Warner, V. Hosagrahara, A. Dudley, P.S. Iyer, S. Narayanan, S. Kavanagh, and V.K. Sambandamurthy. Nature Communications, 2015. 6(6715): 11pp. PMID[25823686].

[PubMed]. OI_0327-040915.


31. Inhibition of Protein Synthesis and Malaria Parasite Development by Drug Targeting of Methionyl-tRNA Synthetases. Hussain, T., M. Yogavel, and A. Sharma. Antimicrobial Agents and Chemotherapy, 2015. 59(4): p. 1856-1867. PMID[25583729].

[PubMed]. OI_0327-040915.


32. Ribifolin, an Orbitide from Jatropha ribifolia, and its Potential Antimalarial Activity. Pinto, M.E., J.M. Batista, Jr., J. Koehbach, P. Gaur, A. Sharma, M. Nakabashi, E.M. Cilli, G.M. Giesel, H. Verli, C.W. Gruber, E.W. Blanch, J.F. Tavares, M.S. Silva, C.R. Garcia, and V.S. Bolzani. Journal of Natural Products, 2015. 78(3): p. 374-380. PMID[25699574].

[PubMed]. OI_0327-040915.


33. Antiplasmodial Activity of Eco-friendly Synthesized Palladium Nanoparticles using Eclipta prostrata Extract against Plasmodium berghei in Swiss Albino Mice. Rajakumar, G., A.A. Rahuman, I.M. Chung, A.V. Kirthi, S. Marimuthu, and K. Anbarasan. Parasitology Research, 2015. 114(4): p. 1397-1406. PMID[25653029].

[PubMed]. OI_0327-040915.


34. Synthesis of 3-Azabicyclo[3.2.2]nonanes and their Antiprotozoal Activities. Seebacher, W., V. Wolkinger, J. Faist, M. Kaiser, R. Brun, R. Saf, F. Bucar, B. Groblacher, A. Brantner, V. Merino, Y. Kalia, L. Scapozza, R. Perozzo, and R. Weis. Bioorganic & Medicinal Chemistry Letters, 2015. 25(7): p. 1390-1393. PMID[25746816].

[PubMed]. OI_0327-040915.


35. Blockade of Erythrocyte Invasion: New Assessment of Anti-reticulocyte-binding Protein Homolog 5 Antibodies. Shen, Y., J. Wang, X. Liu, J. Liang, Y. Huang, Z. Liu, Y.A. Zhao, and Y. Li. Experimental and Therapeutic Medicine, 2015. 9(4): p. 1357-1362. PMID[25780435].

[PubMed]. OI_0327-040915.

Citations from the ISI Web of Knowledge Listings for O.I.

36. Antioxidant, Antimicrobial, Antitumor, and Cytotoxic Activities of an Important Medicinal Plant (Euphorbia royleana) from Pakistan. Ashraf, A., R.A. Sarfraz, M.A. Rashid, and M. Shahid. Journal of Food and Drug Analysis, 2015. 23(1): p. 109-115. ISI[000350265300013].

[WOS]. OI_0327-040915.


37. Nitric Oxide Production, Inhibitory, Antioxidant and Antimycobacterial Activities of the Fruits Extract and Flavonoid Content of Schinus terebinthifolius. Bernardes, N.R., M. Heggdorne-Araujo, I. Borges, F.M. Almeida, E.P. Amaral, E.B. Lasunskaia, M.F. Muzitano, and D.B. Oliveira. Revista Brasileira de Farmacognosia, 2014. 24(6): p. 644-650. ISI[000350314800005].

[WOS]. OI_0327-040915.


38. Essential Oil Composition and Antimicrobial Activity of Vismia macrophylla Leaves and Fruits Collected in Tachira-Venezuela. Buitrago, A., J. Rojas, L. Rojas, J. Velasco, A. Morales, Y. Penaloza, and C. Diaz. Natural Product Communications, 2015. 10(2): p. 375-377. ISI[000349812000044].

[WOS]. OI_0327-040915.


39. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and in Vitro Biological Activities. Devi, P.B., S. Jogula, A.P. Reddy, S. Saxena, J.P. Sridevi, D. Sriram, and P. Yogeeswari. Molecular Informatics, 2015. 34(2-3): p. 147-159. ISI[000350475300008].

[WOS]. OI_0327-040915.


40. DNA Interaction, Cytotoxicity, Antibacterial and Antituberculosis Activity of Oxovanadium(IV) Complexes Derived from Fluoroquinolones and 4-Hydroxy-5-((4-hydroxyphenyl)diazenyl)thiazole-2(3H)-thione. Gajera, S.B., J.V. Mehta, and M.N. Patel. RSC Advances, 2015. 5(28): p. 21710-21719. ISI[000350222400034].

[WOS]. OI_0327-040915.


41. In Vitro Antimicrobial and Antioxidant Evaluation of Rare Earth Metal Schiff Base Complexes Derived from Threonine. Logu, L., K.R. Kamatchi, H. Rajmohan, S. Manohar, R. Gurusamy, and E. Deivanayagam. Applied Organometallic Chemistry, 2015. 29(2): p. 90-95. ISI[000350275000003].

[WOS]. OI_0327-040915.


42. In Vitro and in Vivo Antimicrobial Evaluation of Alkaloidal Extracts of Enantia chlorantha Stem Bark and their Formulated Ointments. Nyong, E.E., M.A. Odeniyi, and J.O. Moody. Acta Poloniae Pharmaceutica, 2015. 72(1): p. 147-152. ISI[000350192000016].

[WOS]. OI_0327-040915.


43. Chemical Composition, Antifungal and Antibacterial Activities of Essential Oil from Lallemantia royleana (Benth. in Wall.) Benth. Sharifi-Rad, J., S.M. Hoseini-Alfatemi, M. Sharifi-Rad, and W.N. Setzer. Journal of Food Safety, 2015. 35(1): p. 19-25. ISI[000350261300003].

[WOS]. OI_0327-040915.


44. New 5-modified 2'-Deoxyuridine Derivatives: Synthesis and Antituberculosis Activity. Shmalenyuk, E.R., I.L. Karpenko, L.N. Chernousova, A.O. Chizhov, T.G. Smirnova, S.N. Andreevskaya, and L.A. Alexandrova. Russian Chemical Bulletin, 2014. 63(5): p. 1197-1200. ISI[000350143000026].

[WOS]. OI_0327-040915.


45. Antimicrobial Compounds from Seaweeds-associated Bacteria and Fungi. Singh, R.P., P. Kumari, and C.R.K. Reddy. Applied Microbiology and Biotechnology, 2015. 99(4): p. 1571-1586. ISI[000350028600003].

[WOS]. OI_0327-040915.


46. Self-assembled Amphotericin B-loaded Polyglutamic acid Nanoparticles: Preparation, Characterization and in Vitro Potential against Candida albicans. Zia, Q., A.A. Khan, Z. Swaleha, and M. Owais. International Journal of Nanomedicine, 2015. 10: p. 1769-1790. ISI[000350606100002].

[WOS]. OI_0327-040915.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024